NYSE - Nasdaq Real Time Price USD
Annovis Bio, Inc. (ANVS)
1.5300
-0.0700
(-4.37%)
At close: May 9 at 4:00:02 PM EDT
1.6000
+0.07
+(4.58%)
After hours: May 9 at 7:48:03 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-21,894.6040
-21,894.6040
-39,967.3040
-17,312.9340
-9,132.1590
Financing Cash Flow
26,691.8000
26,691.8000
17,344.3310
4.6130
46,743.5150
End Cash Position
10,551.9160
10,551.9160
5,754.7200
28,377.6930
45,686.0140
Issuance of Capital Stock
18,666.7970
18,666.7970
16,885.9460
0
46,648.4130
Free Cash Flow
-21,894.6040
-21,894.6040
-39,967.3040
-17,312.9340
-9,132.1590
12/31/2021 - 1/29/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AVXL Anavex Life Sciences Corp.
8.25
-3.62%
SAVA Cassava Sciences, Inc.
1.7700
+4.12%
ACIU AC Immune SA
1.6800
+1.20%
INMB INmune Bio, Inc.
6.97
-1.69%
ANNX Annexon, Inc.
1.6000
-5.88%
ALT Altimmune, Inc.
5.59
-3.62%
MIST Milestone Pharmaceuticals Inc.
1.1100
-7.50%
AXSM Axsome Therapeutics, Inc.
107.76
-1.01%
CGTX Cognition Therapeutics, Inc.
0.3011
-8.76%
CADL Candel Therapeutics, Inc.
4.8100
+1.05%